Metastatic Pancreatic Adenocarcinoma

general

An adenocarcinoma that arises from the exocrine pancreatic tissue and has metastasized to other anatomic sites.

76

Centers

172

Active Trials

$1M

Cancer Funding

Top Centers for Metastatic Pancreatic Adenocarcinoma(76)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
High-Volume Research Center
71.8
2
NCI Comprehensive
High-Volume Research Center
71.8
3
High-Volume Research Center
71.8
4
NCI Clinical
High-Volume Research Center
70.0
5
NCI Comprehensive
High-Volume Research Center
70.0
6
High-Volume Research Center
70.0
7
NCI Comprehensive
Active Research Program
66.8
866.8
9
NCI Comprehensive
Active Research Program
66.8
10
NCI Comprehensive
Active Research Program
66.8
11
NCI Comprehensive
Active Research Program
66.8
12
NCI Clinical
Active Research Program
66.8
13
Active Research Program
66.8
14
Active Research Program
66.8
15
NCI Comprehensive
Active Research Program
59.4
16
NCI Comprehensive
Active Research Program
59.4
17
NCI Comprehensive
Active Research Program
59.4
18
NCI Comprehensive
Active Research Program
59.4
19
NCI Comprehensive
Active Research Program
59.4
20
NCI Comprehensive
Active Research Program
59.4
21
NCI Comprehensive
Active Research Program
59.4
22
NCI Comprehensive
Active Research Program
59.4
23
NCI Comprehensive
Active Research Program
59.4
24
NCI Comprehensive
Active Research Program
59.4
25
NCI Comprehensive
Active Research Program
59.4
26
NCI Comprehensive
Active Research Program
59.4
27
NCI Comprehensive
Active Research Program
59.4
28
Active Research Program
59.4
29
Active Research Program
59.4
30
Active Research Program
59.4
31
Active Research Program
59.4
32
NCI Clinical
Active Research Program
55.5
33
NCI Comprehensive
Active Research Program
49.0
34
NCI Comprehensive
Active Research Program
49.0
35
NCI Comprehensive
Active Research Program
49.0
36
NCI Comprehensive
Active Research Program
49.0
37
NCI Comprehensive
Active Research Program
49.0
38
NCI Comprehensive
Active Research Program
49.0
39
NCI Comprehensive
Active Research Program
49.0
40
NCI Comprehensive
Active Research Program
49.0
41
NCI Comprehensive
Active Research Program
49.0
42
Active Research Program
49.0
43
Active Research Program
49.0
44
NCI Clinical
Active Research Program
49.0
45
NCI Comprehensive
Active Research Program
49.0
46
Active Research Program
49.0
47
Active Research Program
49.0
48
Active Research Program
49.0
49
Active Research Program
49.0
50
Active Research Program
49.0
51
NCI Comprehensive
Active Research Program
47.0
52
NCI Comprehensive
Active Research Program
37.8
53
NCI Comprehensive
Active Research Program
37.8
54
NCI Comprehensive
Active Research Program
37.8
55
NCI Comprehensive
Active Research Program
37.8
56
NCI Comprehensive
Active Research Program
37.8
57
NCI Comprehensive
Active Research Program
37.8
58
Active Research Program
37.8
59
NCI Comprehensive
Active Research Program
37.8
60
NCI Comprehensive
Active Research Program
37.8
61
NCI Comprehensive
Active Research Program
37.8
62
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
Active Research Program
37.8
6337.8
64
Active Research Program
37.8
65
NCI Basic_laboratory
Active Research Program
37.8
66
Active Research Program
37.8
67
Active Research Program
37.8
68
Active Research Program
37.8
69
BC CancerVancouver, BC
Active Research Program
37.8
70
Active Research Program
37.8
7129.8
7229.8
73
NCI Comprehensive
29.8
74
NCI Clinical
29.8
75
Cedars-Sinai CancerLos Angeles, CA
29.8
7629.8

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →